Telfirst M 25 Tablet ER
By Telfirst M
Rx
10 Tablet ER in a Strip

Composition
Telmisartan(40mg) + Metoprolol Succinate(25mg)

Manufacturer - Sinsan Pharmaceuticals
102-103, Park Plaza, Opp. Kamla Nehru Park, Off. Bhandarkar Road, Deccan Gymkhana, Pune, Maharashtra 411004

Expires on or after
September, 2025
About Telfirst M 25 Tablet ER
Telfirst M 25 Tablet ER is a medication that is utilized for the treatment of high blood pressure. By reducing blood pressure levels, this medication plays a crucial role in preventing potential heart attacks and strokes. It is particularly beneficial in enhancing the chances of survival for individuals who have experienced heart attacks.
For optimal effectiveness, it is recommended to consume Telfirst M 25 Tablet ER with food consistently at the same time every day. The objective is to maintain a steady concentration of the medication in the bloodstream. It is imperative to continue taking the medication for the duration advised by your healthcare provider. It is crucial not to discontinue the medication independently, even if you are feeling well, as high blood pressure frequently presents no evident symptoms. Abruptly stopping the medication can deteriorate your condition.
Furthermore, adopting a proactive approach to managing your health by engaging in regular physical activity, managing weight, and adhering to a nutritious diet can assist in regulating blood pressure levels. It is paramount to heed your doctor's guidance while undergoing treatment with Telfirst M 25 Tablet ER.
While this medication is effective, there are potential side effects to be mindful of, such as headaches, weakness, dizziness, reduced blood pressure, elevated potassium levels in the blood, orthostatic hypotension, breathlessness, nausea, vomiting, abdominal discomfort, and fatigue. To mitigate these effects, it is advisable to refrain from consuming potassium-rich foods and supplements during the course of this medication. Exercise caution, as dizziness may occur, and avoid situations like driving or standing up quickly from a seated position.
Regular monitoring of blood pressure, blood sugar levels, kidney function, urea, and electrolytes is recommended throughout the treatment period. Before commencing treatment with Telfirst M 25 Tablet ER, it is essential to inform your healthcare provider of any existing liver or kidney issues. Consultation with a doctor is imperative for pregnant or breastfeeding individuals before initiating this medication. Additionally, disclose all other medications you are currently taking, particularly those prescribed for high blood pressure or heart-related conditions.
Benefits
Telfirst M 25 Tablet ER is highly beneficial in the treatment of hypertension, also known as high blood pressure. When hypertension occurs, the blood vessels that supply blood to the heart become narrow, leading to difficulties in blood flow. As a result, the heart has to work harder to pump blood to other parts of the body, increasing the heart rate and causing potential complications such as chest pain or heart attacks. Telfirst M 25 Tablet ER is specifically designed to address this issue by reducing pressure in the blood vessels and inducing relaxation in them. By doing so, it allows blood to flow more smoothly to the heart, thereby easing the strain on the heart and slowing down the heart rate. What makes this medication even more valuable is its ability to minimize the risk of serious future health issues like strokes, heart attacks, and kidney problems. While you may not perceive immediate effects when taking Telfirst M 25 Tablet ER, its long-term benefits are significant in maintaining your overall well-being. It is crucial to adhere to the prescribed dosage and schedule to maximize the effectiveness of this medication, even if you start feeling better. By incorporating Telfirst M 25 Tablet ER into your routine as directed, you are taking a proactive step towards safeguarding your heart health and reducing the chances of severe cardiovascular complications down the line.
How to use the Telfirst M 25 Tablet ER
To use Telfirst M 25 Tablet ER, follow your doctor's instructions on dosage and duration. Take the tablet by swallowing it whole with food. Do not chew, crush, or break the tablet. Taking this medicine with food helps to improve its effectiveness. Remember to take Telfirst M 25 Tablet ER exactly as prescribed to get the best results from this medication. If you have any questions or concerns about how to use this medicine, consult your doctor or pharmacist for guidance.
Uses of Telfirst M 25 Tablet ER
Telfirst M 25 Tablet ER is primarily used for the treatment of hypertension, which is a medical condition characterized by high blood pressure. By taking these tablets as prescribed by a healthcare professional, patients can effectively manage their blood pressure levels. This medication contains a combination of two active ingredients, Telmisartan and Metoprolol, which work together to help lower blood pressure. It is important to follow the dosage instructions provided by the healthcare provider to ensure optimal results in managing hypertension.
What conditions Telfirst M 25 Tablet ER treats?
Telfirst M 25 Tablet ER is used to treat high blood pressure. High blood pressure, also known as hypertension, can narrow the blood vessels that supply blood to the heart, leading to increased heart rate and decreased blood flow. This strain on the heart can result in chest pain or heart attacks. Telfirst M 25 Tablet ER helps by relaxing the blood vessels, allowing for smoother blood flow to the heart, reducing strain on the heart and lowering heart rate. This lowers the risk of future strokes, heart attacks, and kidney problems. It is important to take this medicine regularly as prescribed even if you feel well.
Should you consult a doctor?
It is important to seek a doctor if you experience persistent side effects such as headaches, weakness, dizziness, cold extremities, slow heart rate, increased potassium levels in the blood, decreased blood pressure, orthostatic hypotension (sudden lowering of blood pressure on standing), breathlessness, vomiting, or abdominal pain while taking Telfirst M 25 Tablet ER. These side effects should not be ignored, especially if they continue or cause concern. Additionally, if you have any existing liver or kidney problems, or if you are pregnant or breastfeeding, it is advisable to consult your doctor before starting this medication. Regular monitoring of blood pressure, blood sugar levels, kidney function, urea, and electrolyte levels may be necessary during treatment. If in doubt or if you have any questions or concerns, always seek advice from your healthcare provider for proper guidance.
Side effects of Telfirst M 25 Tablet ER
When taking Telfirst M 25 Tablet ER, you may experience mild side effects that usually improve as your body gets used to the medication. Common side effects include headaches, weakness, and dizziness. Other possible effects are cold extremities, a slow heart rate, and increased potassium levels in the blood. Some people may also experience decreased blood pressure, orthostatic hypotension (a sudden drop in blood pressure upon standing), breathlessness, vomiting, and abdominal pain. If any of these effects persist or cause concern, it is important to consult your doctor for further guidance.
Safety advice

liver
When using Telfirst M 25 Tablet ER, it is important to be cautious if you have a liver disease. Patients with liver conditions may require a dose adjustment of Telfirst M 25 Tablet ER. It is advised to seek guidance from your doctor before using this medication to ensure it is safe and appropriate for you.

kidney
Telfirst M 25 Tablet ER is safe for patients with kidney disease without the need for dose adjustment.

alcohol
Avoid consuming alcohol while taking Telfirst M 25 Tablet ER as it is considered unsafe. If pregnant, consult your doctor for guidance.

driving
Telfirst M 25 Tablet ER can reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Telfirst M 25 Tablet ER is not safe during pregnancy due to potential risk to the developing baby. In life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Always seek medical advice.

breastfeeding
Telfirst M 25 Tablet ER is likely safe to use while breastfeeding based on limited human data showing no significant risk to the baby.
Consumption warning before consuming Telfirst M 25 Tablet ER
Before consuming Telfirst M 25 Tablet ER, it is crucial to take some precautions for your safety and health. This medicine is primarily used to treat high blood pressure, reducing the risk of heart attacks and strokes. It is recommended to take Telfirst M 25 Tablet ER with food at the same time daily to ensure consistent medication levels in your blood. Consult your doctor to determine the duration of treatment as abruptly stopping the medicine without medical advice can worsen your condition. Although you may feel fine, high blood pressure often shows no symptoms.
Common side effects may include headache, weakness, dizziness, and decreased blood pressure. It is essential to avoid high-potassium foods and supplements while on this medication, as well as to be cautious when driving or changing positions due to the possibility of dizziness. Regular monitoring of various health parameters such as blood pressure, blood sugar, and kidney function may be necessary during treatment. Inform your doctor of any liver or kidney issues before starting this medication, and consult with them if you are pregnant, breastfeeding, or taking other medications for high blood pressure or heart conditions.
What if you forgot to take Telfirst M 25 Tablet ER?
If you forget to take your Telfirst M 25 Tablet ER dose, try to take it as soon as you remember. But if it's nearly time for your next dose, then it's best to skip the missed dose and continue with your routine schedule. It's important not to take a double dose to make up for the one you missed. This ensures you stay on track with your medication plan and helps maintain its effectiveness.
Related lab tests
Related Lab Tests:
When taking Telfirst M 25 Tablet ER, it is important to monitor your kidney function regularly. This can be done through various lab tests that help assess how well your kidneys are working. The following tests are recommended to monitor your kidney function while using Telfirst M 25 Tablet ER:
1. Serum Creatinine Test: Measures the level of creatinine in your blood, a waste product filtered by the kidneys.
2. Blood Urea Nitrogen (BUN) Test: Helps evaluate kidney function by measuring the level of urea nitrogen in the blood.
3. Glomerular Filtration Rate (GFR): Calculates how well your kidneys are filtering waste from the blood.
4. Urinalysis: Analyzes a urine sample to check for the presence of proteins, blood, or abnormal substances that may indicate kidney problems.
Regular monitoring of these lab tests can help ensure that your kidneys are functioning well while taking Telfirst M 25 Tablet ER, and your healthcare provider can adjust your treatment plan accordingly based on the results.
Additional Information
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹156.5
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024